Galderma is a pure-play dermatology company, the world's largest independent dermatology company, with a rich legacy in skin health. Originally founded in 1981 as a joint venture between Nestlé and L'Oréal, it became a wholly-owned subsidiary of Nestlé in 2014 and was operated under the name Nestlé Skin Health. In 2019, Nestlé Skin Health was acquired by a consortium led by EQT, alongside ADIA, PSP Investments, and GIC, and rebranded back to Galderma. The company is dedicated to advancing dermatology for every skin story, offering a comprehensive portfolio of medical and consumer care products across Aesthetics, Consumer Care, and Prescription Medicine. Galderma focuses on science-based solutions to meet the diverse needs of patients and consumers worldwide, leveraging its expertise in skin conditions and aging.
Serves as the central hub for global strategy, corporate functions, and executive leadership, overseeing worldwide operations and R&D.
Modern facilities designed to foster collaboration and innovation, reflecting the company's commitment to advancing dermatological science. Located in a region known for its high quality of life and business-friendly environment.
A dynamic and science-driven environment, encouraging cross-functional collaboration, innovation, and a patient-centric approach. Emphasizes diversity, inclusion, and professional development.
The Zug headquarters symbolizes Galderma's independence and its focused commitment to dermatology, providing a central point for its global network and strategic decision-making.
Galderma operates globally with a presence in approximately 90 countries. Its functions supported globally include cutting-edge research and development centers (e.g., Sweden, Switzerland, USA), state-of-the-art manufacturing facilities (e.g., Sweden, Canada, Brazil, France), extensive commercial operations, sales and marketing teams, medical affairs, and robust supply chain management. This widespread network enables Galderma to deliver its portfolio of prescription medicines, aesthetic solutions, and consumer care products to patients and consumers worldwide.
Zählerweg 10
Zug
ZG
Switzerland
Address: 14501 N. Freeway, Fort Worth, TX 76177, USA
Key hub for North American market access, product launches, and customer engagement, tailoring global strategies to local needs.
Address: Seminariegatan 21, 752 28 Uppsala, Sweden
Drives innovation in aesthetic medicine, leveraging Sweden's strong life sciences research ecosystem. Key site for product development and manufacturing.
Address: Tour Europlaza, 20 Avenue André Prothin, 92400 Courbevoie, La Défense, France
Strengthens Galderma's presence in a key European market, managing local product portfolios and stakeholder relationships.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Galderma' leadership includes:
Galderma has been backed by several prominent investors over the years, including:
Galderma's top executive team has demonstrated stability, particularly leading up to and following its successful IPO in March 2024. While strategic appointments or transitions may occur at various leadership levels to support growth, there have been no major publicly announced C-suite hires or exits in the immediate past 12 months. The focus has been on leveraging the existing strong leadership to drive the company's ambitious agenda in dermatology.
Discover the tools Galderma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Galderma commonly uses standard corporate email formats, typically combining an employee's first name and last name, or first initial and last name, with the @galderma.com domain. Variations may exist for common names or specific departments.
firstname.lastname@galderma.com or firstinitiallastname@galderma.com
Format
jane.doe@galderma.com
Example
85%
Success rate
Reuters • March 22, 2024
Galderma Group AG shares surged on their Zurich stock market debut after the skin-care company owned by EQT AB completed Europe's largest initial public offering since Porsche in 2022, raising $2.3 billion....more
Galderma News • February 29, 2024
Galderma announced robust financial performance for the full year 2023, driven by strong growth across its Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology categories, highlighting significant net sales increase and core EBITDA margin expansion....more
Galderma News • March 8, 2024
Galderma presented significant new research and clinical trial results for its leading dermatology brands at the American Academy of Dermatology (AAD) 2024 Annual Meeting, reinforcing the efficacy and safety profiles of its treatments for various skin conditions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Galderma, are just a search away.